Evidence map›Paper›PMID 30194286›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2018

Inhibition of JAK2/STAT3 Signaling Pathway Suppresses Proliferation of Burkitt's Lymphoma Raji Cells via Cell Cycle Progression, Apoptosis, and Oxidative Stress by Modulating HSP70.

Neng-Wen Xu, Yu Chen, Wei'e Liu, Yan-Jie Chen, Zhi-Min Fan, Min Liu, Lin-Jie Li

Open access · hybridAbstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Neng-Wen XuDepartment of Hematology, Central Hospital of Lishui City, Lishui, Zhejiang, China (mainland).
Yu ChenDepartment of Hematology, Central Hospital of Lishui City, Lishui, Zhejiang, China (mainland).
Wei'e LiuDepartment of Hematology, Central Hospital of Lishui City, Lishui, Zhejiang, China (mainland).
Yan-Jie ChenDepartment of Hematology, Central Hospital of Lishui City, Lishui, Zhejiang, China (mainland).
Zhi-Min FanDepartment of Hematology, Central Hospital of Lishui City, Lishui, Zhejiang, China (mainland).
Min LiuDepartment of Hematology, Central Hospital of Lishui City, Lishui, Zhejiang, China (mainland).
Lin-Jie LiDepartment of Hematology, Central Hospital of Lishui City, Lishui, Zhejiang, China (mainland).
Lishui Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND The aim of this study was to investigate the effect of the JAK2/STAT3 pathway on the proliferation, cell cycle distribution, apoptosis, and oxidative stress of Raji cells via regulating HSP70 expression. MATERIAL AND METHODS Raji cells were divided into Blank, HSP70 siRNA, NC siRNA, AG490 (a JAK2/STAT3 signaling pathway inhibitor), and HSP70 siRNA + rh JAK2 (recombinant human JAK2) groups. HSP70 expression was detected by quantitative real-time reverse transcription-PCR (qRT-PCR); the expression levels of HSP70 and JAK2/STAT3 pathway-related proteins were evaluated by Western blotting; cell proliferation was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays; cell cycle distribution was observed by flow cytometry; cell apoptosis was tested by Annexin V-FITC/PI and Hoechst 33342/PI staining; reactive oxygen species (ROS) production was measured by dichloro-dihydro-fluorescein diacetate (DCFH-DA) assays; and MDA content and SOD and GSH-Px activities were determined using detection kits. RESULTS AG490 obviously down-regulated HSP70 expression, inhibited proliferation, induced cell cycle arrest at the G0/G1 phase, and promoted apoptosis in Raji cells; these effects were similar to the effects of HSP70 siRNA. Furthermore, ROS production and MDA content were increased in Raji cells treated with HSP70 siRNA or AG490, while SOD and GSH-Px activities were reduced. Raji cells in the HSP70 siRNA + rh JAK2 group did not significantly differ from those in the Blank group in regards to proliferation, cell cycle, apoptosis, and oxidative stress. CONCLUSIONS Blocking the JAK2/STAT3 signaling pathway may inhibit proliferation, induce cell cycle arrest, and promote oxidative stress and apoptosis in Raji cells via the down-regulation of HSP70.

Indexed as

ApoptosisApoptosis Regulatory ProteinsBurkitt LymphomaCell CycleCell LineCell MovementCell ProliferationDown-RegulationHSP70 Heat-Shock ProteinsHumansJanus Kinase 2Oxidative StressReactive Oxygen SpeciesRNA, Small InterferingSignal TransductionSTAT3 Transcription Factoralpha-cyano-(3,4-dihydroxy)-N-benzylcinnamideApoptosis Regulatory ProteinsHSP70 Heat-Shock ProteinsJAK2 protein, humanJanus Kinase 2Reactive Oxygen SpeciesRNA, Small InterferingSTAT3 protein, humanSTAT3 Transcription FactorTyrphostins

Identifiers

PMID30194286
PMCPMC6140376
OpenAlexW2891953975

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.